However, in many MM cell lines, ABCB1 expression is very low on the cell surface, and the specific ABCB1 inhibitor tariquidar did not enhance the sensitivity to either bortezomib or carfilzomib, so the relevance to MM biology and proteasome inhibitor resistance is unclear (199). Here, ABCB1 is linked to Miyoshi myopathy.